TIAA CREF Investment Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$7.72M Buy
2014
Q4
$6.98M Sell
2014
Q3
$5.71M Sell
2014
Q2
$9.2M Buy
2014
Q1
$6.71M Sell
2013
Q4
$5.33M Buy
2013
Q3
$4.8M Buy
2013
Q2
$3.16M Buy